Reversible eruption of neurofibromatosis associated with tofacitinib therapy for rheumatoid arthritis.

Rheumatology (Oxford)

Department of Rheumatology, Western Health, Melbourne, Victoria, Australia.

Published: June 2019

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kez012DOI Listing

Publication Analysis

Top Keywords

reversible eruption
4
eruption neurofibromatosis
4
neurofibromatosis associated
4
associated tofacitinib
4
tofacitinib therapy
4
therapy rheumatoid
4
rheumatoid arthritis
4
reversible
1
neurofibromatosis
1
associated
1

Similar Publications

Nanoparticles (NPs) exhibit high reactivity and mobility in the environment, and a significant capacity to penetrate living organisms, potentially leading to harmful effects. Volcanoes are the second major source of natural NPs emitted into the atmosphere, with an estimated flux of 342 Tg/year. Few studies have focused on their fate.

View Article and Find Full Text PDF

Objectives: This study aimed to determine the sequence and eruption chronology of permanent teeth in school children and adolescents of Chennai and compare the findings with an existing standard table. Additionally, the study also attempted to explore the influence of sex, body mass index (BMI), and socioeconomic status (SES) on tooth eruption patterns.

Methods: A cross-sectional study was designed, and 12,650 children aged 5-18 years were selected from thirty-five schools using a multistage random sampling method.

View Article and Find Full Text PDF
Article Synopsis
  • Recent FDA approval of difluoromethylornithine (DFMO) has sparked interest in its potential for preventing various cancers, including keratinocyte carcinomas (KCs), beyond its initial purpose for neuroblastoma in children.
  • A systematic review of 12 studies involving 1,618 predominantly Caucasian patients revealed mixed results, with oral DFMO showing a significant reduction in KCs in only 24% of cases, while topical DFMO showed modest effectiveness in reducing actinic keratosis.
  • Overall, the current evidence does not strongly support the use of oral DFMO, whereas topical DFMO may offer a better option for certain patients in preventing skin cancer.
View Article and Find Full Text PDF

Indeterminate cell histiocytosis (ICH) is a rare histiocytic disorder characterized by a proliferation of CD1a and CD207/langerin cells. Recent molecular analyses have identified ETV3-NCOA2 translocation as a possible aetiopathogenesis of ICH. Herein, we describe the first Japanese case of ICH with ETV3-NCOA2 translocation.

View Article and Find Full Text PDF

Keratoderma-Like T-Cell Dyscrasia: A Case Report.

Case Rep Dermatol

October 2024

Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

Introduction: Cutaneous T-cell dyscrasia (CTCD) encompasses a heterogeneous group of T-cell infiltrates, often clonal and epitheliotropic. While the etiology remains unclear, certain medications, including statins, have been linked to cutaneous T-cell lymphocytic infiltrate development.

Case Description: A patient presented with a pruritic, scaly eruption on her palms and soles unresponsive to topical steroids for 1 month.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!